1. Home
  2. KZIA vs DGLY Comparison

KZIA vs DGLY Comparison

Compare KZIA & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • DGLY
  • Stock Information
  • Founded
  • KZIA 1994
  • DGLY 2004
  • Country
  • KZIA Australia
  • DGLY United States
  • Employees
  • KZIA N/A
  • DGLY N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • KZIA Health Care
  • DGLY Technology
  • Exchange
  • KZIA Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • KZIA 6.0M
  • DGLY 6.3M
  • IPO Year
  • KZIA 1999
  • DGLY N/A
  • Fundamental
  • Price
  • KZIA $0.77
  • DGLY $0.04
  • Analyst Decision
  • KZIA Strong Buy
  • DGLY
  • Analyst Count
  • KZIA 2
  • DGLY 0
  • Target Price
  • KZIA $11.50
  • DGLY N/A
  • AVG Volume (30 Days)
  • KZIA 334.9K
  • DGLY 48.3M
  • Earning Date
  • KZIA 04-11-2025
  • DGLY 05-16-2025
  • Dividend Yield
  • KZIA N/A
  • DGLY N/A
  • EPS Growth
  • KZIA N/A
  • DGLY N/A
  • EPS
  • KZIA N/A
  • DGLY N/A
  • Revenue
  • KZIA $1,655,324.00
  • DGLY $21,131,122.00
  • Revenue This Year
  • KZIA N/A
  • DGLY $22.14
  • Revenue Next Year
  • KZIA N/A
  • DGLY N/A
  • P/E Ratio
  • KZIA N/A
  • DGLY N/A
  • Revenue Growth
  • KZIA 248000.00
  • DGLY N/A
  • 52 Week Low
  • KZIA $0.76
  • DGLY $0.02
  • 52 Week High
  • KZIA $15.80
  • DGLY $3.29
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 35.51
  • DGLY 28.40
  • Support Level
  • KZIA $0.76
  • DGLY $0.03
  • Resistance Level
  • KZIA $1.05
  • DGLY $0.08
  • Average True Range (ATR)
  • KZIA 0.08
  • DGLY 0.01
  • MACD
  • KZIA -0.00
  • DGLY 0.00
  • Stochastic Oscillator
  • KZIA 3.84
  • DGLY 14.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: